Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes
Keywords: داکتاکسل; Uterine leiomyosarcoma; Adjuvant chemotherapy; Gemcitabine; Docetaxel; Survival;